We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Hummingbird Bioscience

News List

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies prnasia
December 07, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK...
Hummingbird Bioscience Announces Trials in Progress Poster Presentation at the Society for Immunotherapy of Cancer 2021 36th Annual Meeting prnasia
November 11, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced a Trials in Progress...
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline biospectrumasia
July 15, 2019
The fundraiser builds upon Hummingbird's recent momentum in receiving a USD 13.1M product development grant from the CPRIT to support Phase IA/B clinical trials of its anti-VISTA antibody for the treatment of solid tumours and lymphomas